Dian Diagnostics Group Co (SZSE:300244) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Dian Diagnostics Group Co Change In Receivables?

Dian Diagnostics Group Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Dian Diagnostics Group Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Dian Diagnostics Group Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥1,969 Mil. It means Dian Diagnostics Group Co's Accounts Receivable declined by ¥1,969 Mil from Dec. 2022 to Dec. 2023 .

Dian Diagnostics Group Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥8,337 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Dian Diagnostics Group Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 255.89.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Dian Diagnostics Group Co's liquidation value for the three months ended in Mar. 2024 was ¥1,769 Mil.

Dian Diagnostics Group Co Change In Receivables Historical Data

The historical data trend for Dian Diagnostics Group Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dian Diagnostics Group Co Change In Receivables Chart

Dian Diagnostics Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-309.50

353.08

-2,030.40

-4,152.34

1,969.13

Dian Diagnostics Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Dian Diagnostics Group Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Dian Diagnostics Group Co (SZSE:300244) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Dian Diagnostics Group Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	8337.193	/	2973.006	*	91
=	255.89

2. In Ben Graham's calculation of liquidation value, Dian Diagnostics Group Co's accounts receivable are only considered to be worth 75% of book value:

Dian Diagnostics Group Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2682.311	-	7945.903	+	0.75 * 8337.193	+	0.5 * 1559.061
=	1,769

Dian Diagnostics Group Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Dian Diagnostics Group Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Dian Diagnostics Group Co (SZSE:300244) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dian Diagnostics Group Co Ltd (SZSE:300244) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 329, Jinpeng Street, 5th Floor, Building 2, Xihu District, Zhejiang, Hangzhou, CHN, 310030

Website

http://www.dazd.cn

Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.

Executives

Chen Hai Bin	Director
Chen Shi Shi	Supervisors
Guo San Hui	Executives
Yao Shu Lie	Executives
Xu Min	Director
Wang Yan Xiao	Directors, executives
Chen Zuo Xiu	Directors, executives
Hu Yong	Director
Hu Miao Shen	Executives
Chen Xue Dong	Director
Jiang Tang	Directors, executives
Tao Jun	Securities Affairs Representative
Wu Zheng Xin	Executives
Cheng Xiu Li	Supervisors

Dian Diagnostics Group Co (SZSE:300244) Headlines

No Headlines